FindTrial
Sign In

leukocyte therapy

BIOLOGICAL2 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences

Conditions

Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative DiseasesUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific

Phase 2

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia
TerminatedNCT00066417
National Heart, Lung, and Blood Institute (NHLBI)Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases
End: 2007-01-31Target: 51Updated: 2013-05-01

Unknown Phase

Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer
WithdrawnNCT00607802
Wake Forest University Health SciencesUnspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
Updated: 2017-01-19